Literature DB >> 28804834

One-Stage Factor VIII Assays.

Elizabeth Duncan1, Susan Rodgers2.   

Abstract

Coagulation factor assays using one-stage methodology are widely used to measure factor levels for the purpose of detecting a deficiency, or to monitor replacement therapy. In this chapter, we focus on a method to measure Factor VIII coagulant activity (FVIII:C) by the one-stage assay (FVIII:C-1), with extra information provided to also allow this method to apply to Factor IX (FIX), Factor XI (FXI), and Factor XII (FXII). From the perspective of laboratory testing, these factors are components of the "intrinsic" coagulation pathway and are all measured in test systems based on the correction of the Activated Partial Thromboplastin Time (APTT). Factor activity is assessed by measuring the ability of an unknown sample to correct the prolonged APTT of factor-deficient plasma (deficient in the factor of interest), relative to the effect of a known calibrator. These assays are used for the diagnosis of the many causes of reduced factor levels, including those causing a prolonged APTT. It is important for laboratory staff to understand the impact of method variations, limitations, and result interpretation and these aspects are also discussed.

Entities:  

Keywords:  Coagulation; Factor IX; Factor VIII; Factor XI; Hemophilia

Mesh:

Substances:

Year:  2017        PMID: 28804834     DOI: 10.1007/978-1-4939-7196-1_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.

Authors:  Yuto Nakajima; Keiji Nogami; Koji Yada; Takeshi Kawamura; Kenichi Ogiwara; Shoko Furukawa; Naruto Shimonishi; Masahiro Takeyama; Midori Shima
Journal:  Int J Hematol       Date:  2019-11-18       Impact factor: 2.490

2.  How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Authors:  Lucia Stanciakova; Miroslava Dobrotova; Pavol Holly; Jana Zolkova; Lubica Vadelova; Ingrid Skornova; Jela Ivankova; Matej Samos; Tomas Bolek; Marian Grendar; Jan Danko; Peter Kubisz; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

3.  Should multiple factor dilutions be performed for all patient coagulation factor assays? Let the debate begin!

Authors:  Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Res Pract Thromb Haemost       Date:  2022-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.